A Pilot Study of Rituximab for the Anticoagulation Resistant Manifestations of Antiphospholipid Syndrome
Clinical trial NCT00537290 · COMPLETED
Trial details
- NCT number
- NCT00537290
- Sponsor
- Hospital for Special Surgery, New York
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-09-01
- Primary completion
- 2013-01-01
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.